These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 38346880)

  • 1. Interventional embolisation for patients with cirrhosis and recurrent or persistent hepatic encephalopathy related to spontaneous portosystemic shunts: protocol for a prospective, non-randomised controlled study.
    Ke Q; Lin T; Lei X; Weng X; He J; Huang X; Li L; Guo WH
    BMJ Open; 2024 Feb; 14(2):e081194. PubMed ID: 38346880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of shunting left/right portal vein branch on post-TIPS hepatic encephalopathy: a study protocol for multicenter randomized blinded controlled trial.
    Ma J; Luo J; Zhang W; Zhou Y; Zhang Z; Yang M; Zhuang Z; Ma L; Yu J; Zhou X; Yan Z
    Trials; 2023 May; 24(1):312. PubMed ID: 37149647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgical portosystemic shunts versus transjugular intrahepatic portosystemic shunt for variceal haemorrhage in people with cirrhosis.
    Brand M; Prodehl L; Ede CJ
    Cochrane Database Syst Rev; 2018 Oct; 10(10):CD001023. PubMed ID: 30378107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of hepatic encephalopathy by administration of rifaximin and lactulose in patients with liver cirrhosis undergoing placement of a transjugular intrahepatic portosystemic shunt (TIPS): a multicentre randomised, double blind, placebo controlled trial (PEARL trial).
    de Wit K; Schaapman JJ; Nevens F; Verbeek J; Coenen S; Cuperus FJC; Kramer M; Tjwa ETTL; Mostafavi N; Dijkgraaf MGW; van Delden OM; Beuers UHW; Coenraad MJ; Takkenberg RB
    BMJ Open Gastroenterol; 2020 Dec; 7(1):. PubMed ID: 33372103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interventional Radiology Management of Hepatic Encephalopathy.
    Lee EW; Liang JJ; McNamara GP
    Clin Liver Dis; 2024 May; 28(2):317-329. PubMed ID: 38548442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Portosystemic shunts versus endoscopic intervention with or without medical treatment for prevention of rebleeding in people with cirrhosis.
    Simonetti RG; Perricone G; Robbins HL; Battula NR; Weickert MO; Sutton R; Khan S
    Cochrane Database Syst Rev; 2020 Oct; 10(10):CD000553. PubMed ID: 33089892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expanded polytetrafluoroethylene (ePTFE)-covered stents versus bare stents for transjugular intrahepatic portosystemic shunt in people with liver cirrhosis.
    Zhu P; Dong S; Sun P; Belgaumkar AP; Sun Y; Cheng X; Zheng Q; Li T
    Cochrane Database Syst Rev; 2023 Aug; 8(8):CD012358. PubMed ID: 37531575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Endovascular therapy accompanied by spontaneous portosystemic shunts for overt hepatic encephalopathy].
    Zhao T; Huang JY; Liu CH; Chen RB; Fan WL; Zheng WL
    Zhonghua Gan Zang Bing Za Zhi; 2023 Feb; 31(2):181-185. PubMed ID: 37137834
    [No Abstract]   [Full Text] [Related]  

  • 9. Association between non-variceal spontaneous portosystemic shunt and outcomes after TIPS in cirrhosis.
    He C; Lv Y; Wang Z; Guo W; Tie J; Li K; Niu J; Zuo L; Yu T; Yuan X; Chen H; Wang Q; Liu H; Bai W; Wang E; Xia D; Luo B; Li X; Yuan J; Han N; Zhu Y; Wang J; Yin Z; Fan D; Han G
    Dig Liver Dis; 2018 Dec; 50(12):1315-1323. PubMed ID: 29960900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Closing spontaneous portosystemic shunts in cirrhosis: Does it make sense? Does it work? What does it take?
    Laleman W; Praktiknjo M; Lauridsen MM; Bonne L; Vanderschueren E; Verslype C; Krag A; Trebicka J; Maleux G
    Metab Brain Dis; 2023 Jun; 38(5):1717-1728. PubMed ID: 36401681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concurrent large spontaneous portosystemic shunt embolization for the prevention of overt hepatic encephalopathy after TIPS: A randomized controlled trial.
    Lv Y; Chen H; Luo B; Bai W; Li K; Wang Z; Xia D; Guo W; Wang Q; Li X; Yuan J; Cai H; Xia J; Yin Z; Fan D; Han G
    Hepatology; 2022 Sep; 76(3):676-688. PubMed ID: 35266571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. To evaluate the prevalence of spontaneous portosystemic shunts in decompensated cirrhosis patients and its prognostic significance.
    Kothari R; Khanna D; Kar P
    Indian J Gastroenterol; 2023 Oct; 42(5):677-685. PubMed ID: 37642937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improvement in survival associated with embolisation of spontaneous portosystemic shunt in patients with recurrent hepatic encephalopathy.
    An J; Kim KW; Han S; Lee J; Lim YS
    Aliment Pharmacol Ther; 2014 Jun; 39(12):1418-26. PubMed ID: 24754260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt (TIPS) according to its severity and temporal grading classification.
    Fonio P; Discalzi A; Calandri M; Doriguzzi Breatta A; Bergamasco L; Martini S; Ottobrelli A; Righi D; Gandini G
    Radiol Med; 2017 Sep; 122(9):713-721. PubMed ID: 28510807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spontaneous portosystemic shunt embolization in liver transplant recipients with recurrent hepatic encephalopathy.
    Álvarez-López P; Campos-Varela I; Quiroga S; Díez I; Charco R; Simón-Talero M; Castells L
    Ann Hepatol; 2022; 27(3):100687. PubMed ID: 35192963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controlling nutritional status score as a new indicator of overt hepatic encephalopathy in cirrhotic patients following transjugular intrahepatic portosystemic shunt.
    Li J; Feng D; Pang N; Zhao C; Gao L; Liu S; Li L
    Clin Nutr; 2022 Feb; 41(2):560-566. PubMed ID: 35032860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of interventional embolization in cirrhotic patients with refractory hepatic encephalopathy associated with spontaneous portosystemic shunts.
    Ke Q; He J; Cai L; Lei X; Huang X; Li L; Liu J; Guo W
    Sci Rep; 2024 Jun; 14(1):14848. PubMed ID: 38937539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Embolization of splenorenal shunt associated to portal vein thrombosis and hepatic encephalopathy.
    Franzoni Lde C; de Carvalho FC; Garzon RG; Yamashiro Fda S; Augusti L; Santos LA; Dorna Mde S; Baima JP; Lima TB; Caramori CA; Silva GF; Romeiro FG
    World J Gastroenterol; 2014 Nov; 20(42):15910-5. PubMed ID: 25400477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transjugular intrahepatic portosystemic shunt and alfapump® system for refractory ascites in liver cirrhosis: Outcomes and complications.
    Will V; Rodrigues SG; Stirnimann G; Gottardi A; Bosch J; Berzigotti A
    United European Gastroenterol J; 2020 Oct; 8(8):961-969. PubMed ID: 32588789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of recurrent severe hepatic encephalopathy in patients with large porto-collaterals shunts or transjugular portosystemic shunt.
    Temmerman F; Laleman W; Maleux G; Nevens F
    Acta Gastroenterol Belg; 2020; 83(1):67-71. PubMed ID: 32233274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.